Australia Flow Cytometry Market (2025-2030)
The Australia Flow Cytometry Market was valued at $31.1 Million in 2025 and projected to reach to $52.6 Million by 2030, representing a compound annual growth rate of 6.8%. Australia's flow cytometry market is positioned for sustained growth driven by increasing healthcare expenditure and technological advancement in diagnostic capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Flow Cytometry Market Trends and Insights
- This 6.8% compound annual growth rate reflects Australia's advancing healthcare infrastructure and increasing adoption of diagnostic technologies across research institutions and clinical laboratories.
- Australia's investment in precision medicine and immunology research is driving demand for flow cytometry instruments and reagents. The Australian market benefits from strong government funding for medical research and a well-established biotechnology sector.
- Australia's healthcare system increasingly relies on flow cytometry for cancer diagnosis, immunological disorders, and hematological assessments.
- The forecast period through 2030 indicates sustained expansion as Australia continues to modernize laboratory capabilities and integrate advanced analytical tools into clinical practice. Australia's position within the Asia Pacific region positions it as a key market for flow cytometry adoption.
- The country's regulatory environment and emphasis on evidence-based diagnostics support market penetration of both established and emerging flow cytometry technologies..
Key Market Statistics
- CAGR (2025-2030) 6.8% CAGR
- Market Size, 2025 ~USD 31.1 Million
- Forecast, 2030 ~USD 52.6 Million
- Country Australia
Australia Flow Cytometry Market Overview
Market Valuation :
Australia's flow cytometry market is valued at $31.1 million in 2025, with strong growth trajectory reaching $52.6 million by 2030, representing a 69% increase over the forecast period.
Growth Rate :
The Australian market is expanding at a 6.8% CAGR, slightly below the global average of 8.7%, reflecting steady but measured adoption of flow cytometry technologies in the region.
Healthcare Infrastructure :
Australia's advanced healthcare system and significant investment in precision medicine initiatives are driving increased adoption of flow cytometry across research institutions, hospitals, and diagnostic laboratories.
Clinical Applications :
Growing demand for flow cytometry in immunology, oncology, and hematology diagnostics is supported by Australia's emphasis on early disease detection and personalized treatment approaches.
Australia Flow Cytometry Market Dynamics
- The country's strong research sector, coupled with government support for precision medicine initiatives, creates favorable conditions for market expansion.
- Australian clinical laboratories and research institutions are progressively adopting flow cytometry for improved patient outcomes and research applications. The forecast period through 2030 will likely see enhanced adoption rates as healthcare providers recognize the diagnostic value of flow cytometry in managing complex diseases.
- Investment in laboratory automation and integration of flow cytometry with digital health platforms will further accelerate market growth.
- Australia's aging population and rising prevalence of chronic diseases will continue to support demand for advanced diagnostic technologies..
Market Ecosystem
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Australia's flow cytometry market is valued at $31.1 million in 2025 and is forecast to reach $52.6 million by 2030, representing a 6.8% CAGR.
- Australia's strong healthcare infrastructure and government research funding drive adoption of flow cytometry across clinical and research laboratories.
- Australia's emphasis on precision medicine and immunological diagnostics creates sustained demand for advanced flow cytometry technologies.
- Australia's regulatory environment and biotechnology sector position the country as a key growth market within the Asia Pacific region.
Flow Cytometry Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ANTIBODIES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8.7% from 2025 to 2030 |
| Largest Segment | REAGENTS & CONSUMABLES (Offering) |
| Market Size Base Year (Billions) | ~USD 5.05 (2025) |
| Revenue Forecast (Billions) | ~USD 7.67 (2030) |
| Segments Covered | Offering, Type |
Australia Flow Cytometry Market Report Segmentation
2 segment dimensions are covered across the global market.
By Offering
- Accessories
- Instruments
- Reagents & Consumables
- Services
- Software
By Type
- Antibodies
- Assays & Kits
- Cell Analyzers
- Cell Sorters
- Other Reagents & Consumables
AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2029 | 2031 | 2033 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 24 | 24.4 | 25 | 26.3 | 28.1 | 32 | 36.9 | 43.3 | 7.1 |
| HOSPITALS & CLINICAL TESTING LABORATORIES | 21 | 21.2 | 21.5 | 22.4 | 23.8 | 26.7 | 30.4 | 35.2 | 6.3 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 9.9 | 9.8 | 9.8 | 10.1 | 10.5 | 11.4 | 12.6 | 14.1 | 4.6 |
| TOTAL | 54.9 | 55.4 | 56.4 | 58.7 | 62.4 | 70.2 | 79.8 | 92.6 | 6.4 |
Target Audience
- Medical Device Manufacturers : Manufacturers need Australia-specific market data to assess market potential, develop localized product strategies, and identify distribution partnerships in this growing healthcare market.
- Healthcare Facility Administrators : Hospital and laboratory administrators require market insights to justify capital investments in flow cytometry equipment and understand competitive positioning within Australia's healthcare sector.
- Research Institutions : Australian research organizations need market intelligence to secure funding, benchmark capabilities against peers, and align research initiatives with market demand and technological trends.
- Investment & Private Equity Firms : Investors evaluating opportunities in Australian healthcare diagnostics require detailed market analysis to assess growth potential, competitive dynamics, and return on investment prospects.
- Healthcare Consultants & Analysts : Consultants advising healthcare clients in Australia need comprehensive market data to develop strategic recommendations, identify market gaps, and support business development initiatives.
Key Companies in the Australia Flow Cytometry Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ABCAM PLC | United Kingdom | Private Company | Primary and secondary antibodies,Conjugated antibodies and conjugation kits,Singleplex immunoassays, |
| BECKMAN COULTER | United States | Private Company | Clinical core lab (chemistry, hematology, immunoassay, urinalysis, integrated systems),Flow cytometry and cellular analysis (clinical and research),Life science research tools (centrifugation, capillary electrophoresis, liquid handling, genomics), |
| INTUITIVE SURGICAL INC | United States | Public Company | da Vinci capital systems,da Vinci instruments, stapling, energy, and accessories,Service, training, and digital programs, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (syringes, needles, IV and vascular access, sharps),Connected Care (infusion pumps, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicines),Diagnostics (clinical instruments and consumables), |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions (reagents, instruments, consumables),Analytical Instruments,Specialty Diagnostics, |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| SONY CORPORATION | Japan | Public Company | Game & Network Services,Music,Pictures, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Research Instruments and Reagents, |
| ENZO BIOCHEM INC. | United States | Private Company | Labels, dyes, and genomic probes,Antibodies and immunoassays,Biochemicals and proteins, |
| SYSMEX CORPORATION | Japan | Public Company | Hematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx for Research),Coagulation diagnostics,Urinalysis and blood gas/electrolyte, |
| CYTEK BIOSCIENCES | United States | Public Company | Aurora / Aurora Evo / Aurora CS spectral systems,Northern Lights and conventional flow cytometers (Guava, Muse, easyCyte),Amnis imaging flow cytometers, |
| BIOMéRIEUX | France | Public Company | Syndromic and low-plex PCR (BIOFIRE, SPOTFIRE, ARGENE),Microbiology ID/AST systems and reagents (VITEK 2, VITEK MS, VITEK REVEAL, API, ETEST),Culture media, CHROMID range, and BACT/ALERT VIRTUO, |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, fermenters, filtration, process chromatography, fluid management),Lab products and services (filtration, purification, water systems, weighing, pipettes, microbiological testing, OEM),Analytical and cell analysis solutions (BLI, cytometry screening, PAT, live-cell imaging, SPR, cell selection), |
| UNION BIOMETRICA, INC. | United States | Private Company | COPAS and related throughput instruments,Contract biological services and assay development,Consumables, support, and upgrades, |
| TAKARA BIO INC. | Japan | Private Company | Genetic and cellular research reagents,Instruments (PCR and cellular analysis devices),In vitro diagnostics (including COVID-19 testing), |
ABCAM PLC
Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees, specializing in life sciences research products and services.
BECKMAN COULTER
Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees, manufacturing laboratory instruments and diagnostic equipment.
INTUITIVE SURGICAL INC
Intuitive Surgical Inc. is a publicly traded United States company founded in 1995 with 17,021 employees, known for developing robotic-assisted surgical systems.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a publicly traded United States company founded in 1897 with 72,000 employees, manufacturing medical devices, laboratory equipment, and diagnostic products.
DANAHER CORPORATION
Danaher Corporation is a publicly traded United States conglomerate founded in 1969 with 59,000 employees, operating across multiple industries including life sciences and diagnostics.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees, providing laboratory equipment, reagents, and analytical instruments globally.
AGILENT TECHNOLOGIES, INC.
Agilent Technologies, Inc. is a publicly traded United States company founded in 1999 with 18,000 employees, specializing in life sciences, diagnostics, and analytical instruments.
SONY CORPORATION
Sony Corporation is a publicly traded Japanese company founded in 1946 with 94,900 employees, operating across electronics, entertainment, and other diversified business segments.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a publicly traded United States company founded in 1952 with 7,450 employees, manufacturing clinical diagnostics and life science research products.
ENZO BIOCHEM INC.
Enzo Biochem Inc. is a United States-based private company founded in 1976 with 131 employees, focused on molecular diagnostics and life sciences research.
SYSMEX CORPORATION
Sysmex Corporation is a publicly traded Japanese company founded in 1968 with 10,861 employees, manufacturing hematology and clinical diagnostics instruments.
CYTEK BIOSCIENCES
Cytek Biosciences is a publicly traded United States company founded in 1992 with 678 employees, developing flow cytometry and cell analysis technologies.
BIOMéRIEUX
bioMérieux is a publicly traded French company founded in 1963 with 14,894 employees, specializing in in vitro diagnostics and microbiology testing solutions.
SARTORIUS AG
Sartorius AG is a publicly traded German company founded in 1870 with 14,242 employees, manufacturing laboratory and bioprocess equipment for life sciences applications.
UNION BIOMETRICA, INC.
Union Biometrica, Inc. is a United States-based private company founded in 1998 with 21 employees, specializing in automated imaging and analysis systems for small organisms.
TAKARA BIO INC.
Takara Bio Inc. is a Japanese private company founded in 2002 with 1,779 employees, providing molecular biology reagents and biotechnology research tools.
Reasons to Buy this Report
- Market Size & Growth Data : Access precise valuation figures for Australia's flow cytometry market with detailed CAGR analysis, enabling accurate financial forecasting and investment decision-making specific to the Australian region.
- Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within Australia's flow cytometry sector to identify partnership opportunities and market entry strategies.
- Regional Adoption Trends : Gain insights into Australia-specific adoption patterns across research institutions, hospitals, and diagnostic laboratories to tailor product offerings and marketing strategies effectively.
- Healthcare Policy Context : Analyze how Australia's precision medicine initiatives and healthcare infrastructure investments impact flow cytometry demand, informing strategic planning and resource allocation.
- Forecast-Driven Strategy : Leverage 2030 market projections to develop long-term business strategies, identify growth segments, and allocate capital efficiently within the Australian healthcare market.
Frequently asked questions
What is the current size of Australia's flow cytometry market?
Australia's flow cytometry market is valued at $31.1 million in 2025 and is expected to grow to $52.6 million by 2030.
What is the growth rate of Australia's flow cytometry market?
Australia's flow cytometry market is growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2030.
What factors are driving growth in Australia's flow cytometry market?
Australia's flow cytometry market growth is driven by advancing healthcare infrastructure, government research funding, increasing adoption of precision medicine, and rising demand for immunological and hematological diagnostics.
Which applications dominate Australia's flow cytometry market?
In Australia, flow cytometry is primarily used for cancer diagnosis, immunological disorder assessment, hematological analysis, and research applications in academic and clinical settings.
How does Australia's flow cytometry market compare to the Asia Pacific region?
Australia represents a significant market within Asia Pacific, with strong regulatory standards and biotechnology infrastructure supporting higher adoption rates of advanced flow cytometry technologies compared to many regional peers.
RESEARCH METHODOLOGY
This research study extensively utilized secondary sources, directories, and databases to identify and collect valuable information for analyzing the global flow cytometry market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was triangulated with primary research inputs to determine the final market size.
Secondary Research
Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the flow cytometry market. The secondary sources used for this study include World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), the Global Cancer Observatory (GLOBOCAN), the World Bank, Eurostat, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the National Institutes of Health (NIH), Institute for Health Metrics and Evaluation (US), International Society for Advancement of Cytometry (US), US FDA, Health Canada, EuroStemCell, German Cancer Research Center, NHS (UK), Cancer Research UK (UK), Stem Cell Foundation, French National Research Agency (France), Italian National Institute of Health, National Cancer Center Japan, Ministry of Science & Technology (India), Australasian Cytometry Society (Australia), the Cytometry Society (India), International Clinical Cytometry Society (US), and African Cancer Registry Network; Lens. Org. National Center for Biotechnology Information (NCBI), corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate & validate the total size of the flow cytometry market. These methods were also used extensively to estimate the size of various market segments.
Flow Cytometry Market : Top-Down and Bottom-Up Approach
Data Triangulation
After evaluating the overall market size through the market size estimation process, the total market was segmented into several subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.
Market Definition
The flow cytometry market is defined as the use of products such as reagents & consumables, instruments, software, accessories, and related services for the identification, characterization, quantification, and sorting of cells and other microscopic particles based on their physical and biochemical properties. Flow cytometry enables multiparameter analysis of characteristics such as cell size, granularity, surface and intracellular markers, DNA/RNA content, cell cycle, viability, apoptosis, proliferation, and functional responses. The report scope includes cell analyzers, cell sorters, antibodies, fluorophores, assays & kits, calibration and control materials, software, accessories, and outsourced flow cytometry services used for cell analysis and sorting workflows. These products and services, applied across research, clinical, pharmaceutical & biotechnology, and industrial applications, are within the report's scope.
Key Stakeholders
- Pharmaceutical & biotechnology companies
- Contract research organizations (CROs)
- Contract development and manufacturing organizations (CDMOs)
- Life science companies
- Academic & research institutes
- Private research institutes
- Venture capitalists & investors
- Market research & consulting firms
- Government associations
- Medical institutions & universities
- Hospitals & clinics
Report Objectives
- To define, describe, and forecast the flow cytometry market based on product, technology, detection modality, application, end user (product), service type, end user (service), and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall flow cytometry market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players in the flow cytometry market and comprehensively analyze their core competencies and market rankings
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the flow cytometry market
- To benchmark players within the flow cytometry market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy
Available customizations:
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Geographic Analysis
- Further breakdown of the Rest of Europe flow cytometry market, by country
- Further breakdown of the Rest of Asia Pacific flow cytometry market, by country
- Further breakdown of the Rest of Latin America flow cytometry market, by country
- Further breakdown of the Rest of Middle East flow cytometry market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Get the Full Flow Cytometry Market Report
Full forecast, segment splits, and company analysis for all Flow Cytometry Market.
- US Flow Cytometry Market
- Canada Flow Cytometry Market
- Germany Flow Cytometry Market
- UK Flow Cytometry Market
- France Flow Cytometry Market
- Italy Flow Cytometry Market
- Spain Flow Cytometry Market
- China Flow Cytometry Market
- Japan Flow Cytometry Market
- India Flow Cytometry Market
- South Korea Flow Cytometry Market
- Singapore Flow Cytometry Market
- Indonesia Flow Cytometry Market
- Brazil Flow Cytometry Market
- Mexico Flow Cytometry Market
- Saudi Arabia Flow Cytometry Market
- UAE Flow Cytometry Market
- Rest Of Europe Flow Cytometry Market
- Rest Of Asia Pacific Flow Cytometry Market
- Rest Of Latin America Flow Cytometry Market
- GCC Countries Flow Cytometry Market
- Rest Of Middle East Flow Cytometry Market
- Rest Of GCC Countries Flow Cytometry Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
